Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Coronavirus Screening Test Developed by Johns Hopkins Microbiologists

By LabMedica International staff writers
Posted on 20 Mar 2020
A team of clinical microbiologists from John Hopkins University (Baltimore, MD) have developed an in-house coronavirus screening test that could allow the health system to test about 1,000 people daily. More...
The test would help people to quickly learn if they are infected with COVID-19 and also allow doctors to test people with whom such patients have come in contact.

The test, which analyzes a nasal or oral swab, was used for the first time on March 11 by the microbiologists who performed around 85 tests during the first three days. The team expects to quickly ramp up capacity and test 180 people per day next week and 500 people in the week after that to reach 1,000 tests per day by early April. Currently, the test delivers results in about 24 hours, which the doctors hope to shorten to three hours.

“We will be able to diagnose more cases. This will allow the control of exposure,” said Heba Mostafa, M.B.B.Ch., Ph.D., assistant professor of pathology and director of the molecular virology laboratory at The Johns Hopkins Hospital.

“Testing is very important in terms of identifying cases so epidemiologists can then contact people exposed to individuals who are known to be positive and make recommendations about home isolation and further follow-up,” added Karen Carroll, M.D., professor of pathology and director of the Division of Medical Microbiology at Johns Hopkins.

Related Links:
John Hopkins University


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Online QC Software
Acusera 24•7
Automated Urinalysis Solution
UN-9000
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Spatial profiling of muscle-invasive bladder cancer reveals how distinct tumor cell states are organized within individual tumors (Image Credit: Shutterstock)

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer is clinically heterogeneous, with patients often responding very differently to therapy. Existing biomarkers do not fully explain these disparities, limiting precision treatment... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.